• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Celldex Therapeutics Inc

+ Add to Watchlist

TCE1:GR

14.016 EUR 0.874 5.87%

As of 15:14:35 ET on 12/23/2014.

Snapshot for Celldex Therapeutics Inc (TCE1)

Open: 15.003 Day's Range: 14.016 - 15.113 Volume: 0
Previous Close: 14.890 52wk Range: 7.887 - 23.891 1-Yr Rtn: -18.12%

Stock Chart for TCE1

No chart data available.
  • TCE1:GR 14.985
  • 1D
  • 1M
  • 1Y
14.890
Interactive TCE1 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TCE1

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.3180
Est. PEG Ratio -
Market Cap (M EUR) 1,255.68
Shares Outstanding (M) 89.59
30 Day Average Volume 601
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/03/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TCE1

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TCE1

Celldex Therapeutics Inc., a biopharmaceutical company, uses applications of immunology to prevent and treat diseases. The Company's products treat autoimmune diseases, cardiovascular diseases, cancer, and inflammation, as well as infectious diseases and organ transplant rejection.

Anthony Salvatore MarucciPresident/CEOThomas DavisExec VP/Chief Medical Officer
Tibor KelerExec VP/Chief Scientific OfficerAvery W Catlin "Chip"Senior VP/CFO/Secretary
More Company Profile & Key Executives for TCE1

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil